default author photo

Wu-tong Ju

Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology

SCHOLARLY PAPERS

1

DOWNLOADS

103

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Neoadjuvant Immunochemotherapy for Locally Advanced Resectable Oral Squamous Cell Carcinoma: A Prospective Single-Arm Trial

Number of pages: 29 Posted: 21 Dec 2022
Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral Pathology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Radiology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Huangpu Branch, Shanghai Jiao Tong University (SJTU) - Department of Biostatistics, Shanghai Jiao Tong University (SJTU) - Department of Radiology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral Pathology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, 3D Medicines, Inc. - Medical Department, 3D Medicines, Inc. - Medical Department, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology and Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology
Downloads 103 (674,591)

Abstract:

Loading...

Neoadjuvant immunochemotherapy, PD-1 inhibitor, Oral squamous cell carcinoma, Major pathological response